RBL1 and mesothelioma: The results of initial experiments with the AKT inhibitor AKTi VIII suggested a role of AKT in modulating RBL1/p107 levels/activity in lung cancer and mesothelioma cells, as in fact AKT inhibition affected RBL1/p107 levels as well as phosphorylation.